Novel Psychoactive Substances in Young Adults with and without Psychiatric Comorbidities

Abstract

The use of novel psychoactive substances in a young psychiatric population appears to be a frequent phenomenon, probably still underestimated. Therefore, careful and constant monitoring and accurate evaluations of possible clinical effects related to their use are necessary.